Effects of caffeine intake on the pharmacokinetics of melatonin, a probe drug for CYP1A2 activity
- PMID: 14616429
- PMCID: PMC1884289
- DOI: 10.1046/j.1365-2125.2003.01933.x
Effects of caffeine intake on the pharmacokinetics of melatonin, a probe drug for CYP1A2 activity
Abstract
Aims: The aim of this study was to assess the influence of concomitant caffeine intake on the pharmacokinetics of oral melatonin, a probe drug for CYP1A2 activity.
Methods: Twelve healthy subjects, six smokers and six nonsmokers, were given melatonin (6 mg) either alone or in combination with caffeine (3 x 200 mg). Blood samples for the analysis of melatonin or caffeine and paraxanthine were taken from 1 h before until 6 h after intake of melatonin. Subjects were genotyped with respect to the CYP1A2*1F (C734A) polymorphism.
Results: When caffeine was coadministered the Cmax and AUC of melatonin were increased on average by 142% (P = 0.001, confidence interval on the difference 44, 80%) and 120% (P < 0.001, confidence interval on the difference 63, 178%), respectively. The inhibitory effect of caffeine was more pronounced in nonsmokers and in individuals with the *1F/*1F genotype.
Conclusion: The results of this study revealed a pronounced effect of caffeine on the bioavailability of orally given melatonin, most probably due to inhibition of CYP1A2 activity.
Figures
Similar articles
-
Effect of caffeine intake 12 or 24 hours prior to melatonin intake and CYP1A2*1F polymorphism on CYP1A2 phenotyping by melatonin.Basic Clin Pharmacol Toxicol. 2006 Oct;99(4):300-4. doi: 10.1111/j.1742-7843.2006.pto_491.x. Basic Clin Pharmacol Toxicol. 2006. PMID: 17040215
-
Orally given melatonin may serve as a probe drug for cytochrome P450 1A2 activity in vivo: a pilot study.Clin Pharmacol Ther. 2001 Jul;70(1):10-6. doi: 10.1067/mcp.2001.116512. Clin Pharmacol Ther. 2001. PMID: 11452239
-
The effect of oral contraceptives on the pharmacokinetics of melatonin in healthy subjects with CYP1A2 g.-163C>A polymorphism.J Clin Pharmacol. 2008 Aug;48(8):986-94. doi: 10.1177/0091270008318669. Epub 2008 May 19. J Clin Pharmacol. 2008. PMID: 18490497
-
Assessment of CYP1A2 activity in clinical practice: why, how, and when?Basic Clin Pharmacol Toxicol. 2005 Sep;97(3):125-34. doi: 10.1111/j.1742-7843.2005.pto_973160.x. Basic Clin Pharmacol Toxicol. 2005. PMID: 16128905 Review.
-
Measurement of CYP1A2 activity: a focus on caffeine as a probe.Curr Drug Metab. 2012 Jun 1;13(5):667-78. doi: 10.2174/1389200211209050667. Curr Drug Metab. 2012. PMID: 22554278 Review.
Cited by
-
Clinical pharmacokinetics of melatonin: a systematic review.Eur J Clin Pharmacol. 2015 Aug;71(8):901-9. doi: 10.1007/s00228-015-1873-4. Epub 2015 May 27. Eur J Clin Pharmacol. 2015. PMID: 26008214 Review.
-
Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults.Clin Interv Aging. 2023 Jan 12;18:49-59. doi: 10.2147/CIA.S361519. eCollection 2023. Clin Interv Aging. 2023. PMID: 36660543 Free PMC article. Review.
-
Adverse Events Associated with Melatonin for the Treatment of Primary or Secondary Sleep Disorders: A Systematic Review.CNS Drugs. 2019 Dec;33(12):1167-1186. doi: 10.1007/s40263-019-00680-w. CNS Drugs. 2019. PMID: 31722088
-
Candidate Proficiency Test Chemicals to Address Industrial Chemical Applicability Domains for in vitro Human Cytochrome P450 Enzyme Induction.Front Toxicol. 2022 Jun 20;4:880818. doi: 10.3389/ftox.2022.880818. eCollection 2022. Front Toxicol. 2022. PMID: 35795225 Free PMC article. Review.
-
Melatonin-Caffeine Combination Modulates Gamma Radiation-induced Sperm Malformations in C57BL/6 Male Mice at Sublethal Dose of Gamma Radiation.J Pharm Bioallied Sci. 2021 Apr-Jun;13(2):268-275. doi: 10.4103/jpbs.JPBS_303_20. Epub 2021 May 25. J Pharm Bioallied Sci. 2021. PMID: 34349489 Free PMC article.
References
-
- Landi MT, Sinha R, Lang NP, Kadlubar FF. Human cytochrome P4501A2. In: Ryder W, editor. Metabolic Polymorphisms and Susceptibility to Cancer. Lyon: IARC; 1999. pp. 173–195. Scientific Publications no. 148. - PubMed
-
- Bock KW, Schrenk D, Forster A, et al. The influence of environmental and genetic factors on CYP2D6, CYP1A2 and UDP-glucuronosyltransferases in man using sparteine, caffeine, and paracetamol as probes. Pharmacogenetics. 1994;4:209–218. - PubMed
-
- Lampe JW, King IB, Li S, et al. Brassica vegetables increase and apiaceous vegetables decrease cytochrome P450 1A2 activity in humans: changes in caffeine metabolite ratios in response to controlled vegetable diets. Carcinogenesis. 2000;21:1157–1162. - PubMed
-
- Rost KL, Roots I. Accelerated caffeine metabolism after omeprazole treatment is indicated by urinary metabolite ratios. Coincidence with plasma clearance and breath test. Clin Pharmacol Ther. 1994;55:402–411. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical